drugset / Trial / NCT07146893
Feasibility Study for Repurposing RET Inhibitors
Phase 0
Not yet recruiting
7 enrolled
University of Oklahoma
Presbyterian Health Foundation · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the effects of selpercatinib on cachexia and anorexia in patients diagnosed with NSCLC, colorectal cancer, or pancreatic cancer.
Timeline
- Start
- 2026-02-26
- Primary completion
- 2027-02-23
- Completion
- 2028-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Selpercatinib | Small molecule | — | Oral |
Indications
No indication recorded.